Market Place
Sourcing Support
All News #Library
Biotech
Virion Therapeutics Shows Strong, Lasting Anti-HBV Response
22 Feb 2026 //
BUSINESSWIRE
Virion Shows Sustained HBsAg Decline After Single VRON-0200 Dose
09 Nov 2025 //
BUSINESSWIRE
Virion To Present HBV Functional Cure Data From VRON-0200 Study
07 Oct 2025 //
PHARMIWEB
Virion Therapeutics Reports Positive Clinical Data with VRON-0200
28 Mar 2025 //
PR NEWSWIRE
Virion Completes Enrollment of Phase 1b Chronic Hepatitis B Trial
10 Jan 2025 //
PR NEWSWIRE
Virion Reports Clinical Responses with VRON-0200 at AASLD 2024
19 Nov 2024 //
PR NEWSWIRE
Virion: Positive Phase 1b VRON-0200 Immunogenicity In HBV At EASL
05 Jun 2024 //
PR NEWSWIRE
Ocean Bio: JV Partner Virion`s VRON-0200 Shows Positive HBV Immunogenicity
05 Jun 2024 //
GLOBENEWSWIRE
Promising First-In-Human Phase 1B Clinical Study Data from VRON-0200 at Meeting
27 Mar 2024 //
PR NEWSWIRE
Virion Presents VRON-0200 Preclinical Data Showing Direct Correlations
21 Jun 2023 //
PR NEWSWIRE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.